Bull case
PG would need investors to value it at roughly 29x earnings — about 7x more generous than today's 22x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where PG stock could go
PG would need investors to value it at roughly 29x earnings — about 7x more generous than today's 22x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
This is close to how the market is already pricing PG — at roughly 22x forward earnings. No dramatic re-rating needed, just steady execution on the core business.
If investor confidence fades or macro conditions deteriorate, a 8x multiple contraction could push PG down roughly 37% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Procter & Gamble is a global consumer goods giant that sells everyday household products across beauty, grooming, health, fabric care, and baby care categories. It generates revenue primarily through product sales across its five main segments — Fabric & Home Care (~35% of sales), Baby & Family Care (~25%), Health Care (~15%), Beauty (~15%), and Grooming (~10%). Its competitive moat lies in its massive portfolio of iconic, trusted brands — like Tide, Pampers, and Gillette — that enjoy deep consumer loyalty and dominate retail shelf space worldwide.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $1.48/$1.42 | +4.2% | $20.9B/$20.8B | +0.2% |
| Q4 2025 | $1.99/$1.90 | +4.7% | $22.4B/$22.2B | +0.9% |
| Q1 2026 | $1.88/$1.86 | +1.1% | $22.2B/$22.3B | -0.4% |
| Q2 2026 | $1.59/$1.56 | +1.9% | $21.2B/$20.5B | +3.4% |
PG beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $122 — implies -19.1% from today's price.
| Metric | PG | S&P 500 | Consumer Defensive | 5Y Avg PG |
|---|---|---|---|---|
| Forward PE | 21.8x | 18.8x+16% | 14.2x+54% | — |
| Trailing PE | 23.1x | 24.4x | 18.9x+22% | 25.4x |
| PEG Ratio | 4.13x | 1.66x+149% | 1.92x+115% | — |
| EV/EBITDA | 16.2x | 15.2x | 11.1x+46% | 18.9x-14% |
| Price/FCF | 25.0x | 20.7x+21% | 15.3x+64% | 25.9x |
| Price/Sales | 4.2x | 3.1x+35% | 0.9x+374% | 4.7x-10% |
| Dividend Yield | 2.67% | 1.91% | 3.06% | 2.39% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolPG generates $15.0B in free cash flow at a 17.3% margin — 20.1% ROIC signals a durable competitive advantage · returns 4.5% of market cap to shareholders annually.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
~1.7 years to full repayment at current FCF run-rate
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated June 17, 2026
Shifting consumer behavior is negatively impacting Procter & Gamble's performance, contributing to a 13% year-to-date decline in share price.
Recessionary fears in the U.S. and globally may create significant challenges for Procter & Gamble in 2026, potentially worsening its already modest 2% growth rate.
Procter & Gamble disclosed 19 risk factors in its most recent earnings report, indicating numerous potential challenges across its business operations.
As a mature blue-chip company, Procter & Gamble faces inherent limitations to rapid growth, with investors primarily valuing stability and dividends over expansion.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated June 17, 2026
PG's trailing and forward P/E ratios indicate a stable and attractive valuation for investors.
Multiple bullish theses from Value investing subreddit and Investing Lawyer's Substack highlight positive investor outlook.
The bull case suggests a 28% implied upside, indicating significant growth potential.
PG's consistent performance and growth make it a reliable hold in the current market.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
PG PG The Procter & Gamble Company | $351.4B | 21.8x | +1.3% | 14.7% | Buy | +5.7% |
UL UL Unilever PLC | $127.6B | 18.4x | +2.5% | 10.2% | Hold | +21.6% |
KMB KMB Kimberly-Clark Corporation | $34.0B | 13.6x | +0.6% | 12.8% | Hold | +3.8% |
CL CL Colgate-Palmolive Company | $71.8B | 23.5x | +4.1% | 10.5% | Hold | +7.3% |
CHD CHD Church & Dwight Co., Inc. | $22.7B | 25.5x | +4.3% | 11.8% | Buy | +9.8% |
ENR ENR Energizer Holdings, Inc. | $1.5B | 6.1x | +1.7% | 6.5% | Hold | +6.9% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
PG returns 4.5% total yield, led by a 2.67% dividend, raised 56 consecutive years. Buybacks add another 1.8%.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $2.15 | — | — | — |
| 2025 | $4.18 | +5.5% | 1.7% | 4.2% |
| 2024 | $3.96 | +6.0% | 1.2% | 3.5% |
| 2023 | $3.74 | +3.5% | 2.0% | 4.3% |
| 2022 | $3.61 | +6.2% | 2.7% | 5.1% |
Common questions answered from live analyst data and company financials.
The Procter & Gamble Company (PG) is rated Buy by Wall Street analysts as of 2026. Of 52 analysts covering the stock, 28 rate it Buy or Strong Buy, 23 rate it Hold, and 1 rate it Sell or Strong Sell. The consensus 12-month price target is $159, implying +5.7% from the current price of $150. The bear case scenario is $95 and the bull case is $199.
The Wall Street consensus price target for PG is $159 based on 52 analyst estimates. The high-end target is $172 (+14.4% from today), and the low-end target is $142 (-5.6%). The base case model target is $151.
PG trades at 21.8x times forward earnings. The stock's valuation is broadly in line with the broader market. Based on current multiples versus the peer group, the relative model signals slightly expensive versus peers. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for PG in 2026 are: (1) Macroeconomic headwinds — Recessionary fears in the U. (2) Consumer behavior shifts — Shifting consumer behavior is negatively impacting Procter & Gamble's performance, contributing to a 13% year-to-date decline in share price. (3) Multiple risk factors — Procter & Gamble disclosed 19 risk factors in its most recent earnings report, indicating numerous potential challenges across its business operations. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates PG will report consensus revenue of $87.8B (+1.3% year-over-year) and EPS of $6.27 (+19.1% year-over-year) for the upcoming fiscal year. The following year, analysts project $89.1B in revenue.
The Procter & Gamble Company is expected to report its next earnings on approximately 2026-07-29. Consensus expects EPS of $1.44 and revenue of $21.4B. Over recent quarters, PG has beaten EPS estimates 92% of the time.
The Procter & Gamble Company (PG) generated $15.0B in free cash flow over the trailing twelve months — a free cash flow margin of 17.3%. PG returns capital to shareholders through dividends (2.7% yield) and share repurchases ($6.5B TTM).